Market Chatter: Telik Surges 50% Following Removal from Halt - Rumored To Have Obtained Orphan Drug Status for Telintra
Only news I could find was in my Fidelity account...I have no idea who "MidnightTrader" is and I'm not trying to pump his site.
— 2:09 PM ET 01/11/2013
02:09 PM EST, 01/11/2013 (MidnightTrader) -- Telik Inc. (TELK) shares are up more than 50% and have hit a day high $2.69 after resuming trading following a volatility halt. According to various Internet reports it was granted orphan drug status for Telintra for myelodysplastic syndrome. Whether or not this is true can not be confirmed at this point. Neither the FDA or TELK have issued a statement on Telintra's status.
Price: 2.20, Change: +0.75, Percent Change: +51.7